Neoadjuvant hormone therapy before radical prostatectomy does not improve disease-specific survival

被引：2
|
作者：
Steiner M.S. [1 ]
机构：
[1] Department of Urology, University of Tennessee, Memphis, 956 Court Avenue, Room H216, Memphis, 38163, TN
来源：
Current Urology Reports | 2000年 / 1卷 / 1期
关键词：
Biochemical Recurrence; Flutamide; Prostate Cancer; Prostate Cancer Cell; Radical Prostatectomy;
D O I：
10.1007/s11934-000-0028-y
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：7 / 8
页数：1
相关论文
共 50 条
  • [1] Early radical prostatectomy improves disease-specific but not overall survival
    Cunningham, DC
    Newton, WP
    JOURNAL OF FAMILY PRACTICE, 2003, 52 (01): : 22 - 23
  • [2] Overall and disease-specific survival after radical prostatectomy: Geographic uniformity
    Lai, SH
    Lai, H
    Krongrad, A
    Roos, BA
    UROLOGY, 2001, 57 (03) : 504 - 509
  • [3] Significance of neoadjuvant therapy before radical prostatectomy
    Paul, R
    van Randenborgh, H
    Kübler, H
    Alschibaja, M
    Hartung, R
    UROLOGE A, 2004, 43 (06): : 680 - +
  • [4] Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
    Pai, Howard Huaihan
    Eldridge, Brenna
    Bishop, Darcy
    Alexander, Abraham
    Lesperance, Mary
    Blood, Paul
    Lim, Jan
    Ludgate, Charles
    CANADIAN JOURNAL OF UROLOGY, 2009, 16 (02) : 4541 - 4552
  • [5] Neoadjuvant therapy before radical prostatectomy - indications and protocols
    Lamche, Michael
    Schramek, Paul
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2011, 161 (15-16) : 374 - 376
  • [6] Neoadjuvant hormonal therapy before radical prostatectomy indicated?
    Chun, J
    Pruthi, RS
    UROLOGIA INTERNATIONALIS, 2004, 72 (04) : 275 - 280
  • [7] HORMONE ABLATION THERAPY AS NEOADJUVANT TREATMENT TO RADICAL PROSTATECTOMY
    SOLOMON, MH
    MCHUGH, TA
    DORR, RP
    LEE, F
    SIDERS, DB
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1993, 16 (06): : 532 - 538
  • [8] Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failure
    Meyer, F
    Moore, L
    Bairati, I
    Lacombe, L
    Têtu, B
    Fradet, Y
    JOURNAL OF UROLOGY, 1999, 162 (06): : 2024 - 2028
  • [9] Radical prostatectomy may improve disease-specific mortality, but not overall survival compared with watchful waiting in early prostate cancer
    Drachenberg, DE
    CANCER TREATMENT REVIEWS, 2003, 29 (03) : 231 - 233
  • [10] Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level
    Tiguert, R
    Rigaud, J
    Lacombe, L
    Laverdière, J
    Fradet, Y
    JOURNAL OF UROLOGY, 2003, 170 (02): : 447 - 450
12345